In our analysis of the CMV dataset as shown in Figure S6, we identified NKG2C and CD57 as highly predictive markers for CMV classification at day 0, highlighting their potential role in early immune responses to CMV infection. The gene discussed is B3GAT1; the disease is cytomegalovirus infection.